Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia.

Eckerström C, Olsson E, Bjerke M, Malmgren H, Edman A, Wallin A, Nordlund A.

J Alzheimers Dis. 2013;36(3):421-31. doi: 10.3233/JAD-122440.

PMID:
23635408
2.

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.

Frankfort SV, Tulner LR, van Campen JP, Verbeek MM, Jansen RW, Beijnen JH.

Curr Clin Pharmacol. 2008 May;3(2):123-31. Review.

PMID:
18700307
3.

[Use of cerebrospinal fluid (CSF) biomarkers for Alzheimer's type dementia: diagnosis in mild cognitive impairment].

Verhey FR, Visser PJ.

Ned Tijdschr Geneeskd. 2013;157(11):A5596. Review. Dutch.

PMID:
23484512
4.

Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease.

Gainotti G, Quaranta D, Vita MG, Marra C.

J Alzheimers Dis. 2014;38(3):481-95. doi: 10.3233/JAD-130881. Review.

PMID:
24002185
5.

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.

Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB.

J Alzheimers Dis. 2011;26 Suppl 3:159-99. doi: 10.3233/JAD-2011-0043. Review.

PMID:
21971460
6.

Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.

Forlenza OV, Diniz BS, Teixeira AL, Stella F, Gattaz W.

Rev Bras Psiquiatr. 2013 Jul-Sep;35(3):284-94. doi: 10.1590/1516-4446-2012-3505. Review.

7.

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis.

Ferreira D, Rivero-Santana A, Perestelo-Pérez L, Westman E, Wahlund LO, Sarría A, Serrano-Aguilar P.

Front Aging Neurosci. 2014 Oct 16;6:287. doi: 10.3389/fnagi.2014.00287. eCollection 2014. Review.

8.

Emerging biomarkers in cognition.

Wicklund M, Petersen RC.

Clin Geriatr Med. 2013 Nov;29(4):809-28. doi: 10.1016/j.cger.2013.07.006. Review.

9.

Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia.

Forlenza OV, Diniz BS, Stella F, Teixeira AL, Gattaz WF.

Rev Bras Psiquiatr. 2013 Apr-Jun;35(2):178-85. Review.

10.

The Times They Are a-Changin': Clock Drawing and Prediction of Dementia.

Amodeo S, Mainland BJ, Herrmann N, Shulman KI.

J Geriatr Psychiatry Neurol. 2015 Jun;28(2):145-55. doi: 10.1177/0891988714554709. Epub 2014 Oct 14. Review.

PMID:
25319477
11.

Remember to buy milk on the way home! A meta-analytic review of prospective memory in mild cognitive impairment and dementia.

van den Berg E, Kant N, Postma A.

J Int Neuropsychol Soc. 2012 Jul;18(4):706-16. doi: 10.1017/S1355617712000331. Epub 2012 May 18. Review.

PMID:
22595831
12.

Risk factors for the progression of mild cognitive impairment to dementia.

Campbell NL, Unverzagt F, LaMantia MA, Khan BA, Boustani MA.

Clin Geriatr Med. 2013 Nov;29(4):873-93. doi: 10.1016/j.cger.2013.07.009. Review.

PMID:
24094301
13.

Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.

Torosyan N, Silverman DH.

Semin Nucl Med. 2012 Nov;42(6):415-22. doi: 10.1053/j.semnuclmed.2012.06.004. Review.

14.

Biochemical investigations in patients with dementia.

Green A.

Ann Clin Biochem. 2002 May;39(Pt 3):211-20. Review.

PMID:
12038595
15.

Diagnosing early cognitive decline-When, how and for whom?

Allan CL, Behrman S, Ebmeier KP, Valkanova V.

Maturitas. 2017 Feb;96:103-108. doi: 10.1016/j.maturitas.2016.11.018. Epub 2016 Dec 1. Review.

PMID:
28041588
16.

Biomarkers in dementia: clinical utility and new directions.

Ahmed RM, Paterson RW, Warren JD, Zetterberg H, O'Brien JT, Fox NC, Halliday GM, Schott JM.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1426-34. doi: 10.1136/jnnp-2014-307662. Epub 2014 Sep 26. Review.

17.

The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.

Henderson TA.

CNS Spectr. 2012 Dec;17(4):176-206. doi: 10.1017/S1092852912000636. Epub 2012 Aug 29. Review.

PMID:
22929226
18.

Challenges of diagnosing dementia in the oldest old population.

Slavin MJ, Brodaty H, Sachdev PS.

J Gerontol A Biol Sci Med Sci. 2013 Sep;68(9):1103-11. doi: 10.1093/gerona/glt051. Epub 2013 May 17. Review.

PMID:
23685769
19.

Consent for the diagnosis of preclinical dementia states: A review.

Hughes JC, Ingram TA, Jarvis A, Denton E, Lampshire Z, Wernham C.

Maturitas. 2017 Apr;98:30-34. doi: 10.1016/j.maturitas.2017.01.008. Epub 2017 Jan 19. Review.

PMID:
28274325

Supplemental Content

Support Center